Inventor · disambiguated record
Jason D. Brubaker
Also filed as: BRUBAKER JASON · BRUBAKER JASON D
45 granted patents·6 pending applications·292 citations·filing 2005–2024
98Inventor score
Files withBLUEPRINT MEDICINES CORP20MERCK SHARP & DOHME10HARVARD COLLEGE8BRUBAKER JASON4MYERS ANDREW G4
Top patents by PatentIndex Score
51 records- 0198US10030005B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2016·Granted Jul 24, 2018·38 cites·30 claims
- 0297US11279688B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2020·Granted Mar 22, 2022·5 cites·2 claims
- 0397US7763735B2Synthesis of enone intermediateHARVARD COLLEGE·Filed 2007·Granted Jul 27, 2010·28 cites·19 claims
- 0496US10227329B2Compounds useful for treating disorders related to RETBLUEPRINT MEDICINES CORP·Filed 2017·Granted Mar 12, 2019·19 cites·21 claims
- 0595US10584114B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2018·Granted Mar 10, 2020·13 cites·3 claims
- 0695US10183928B2Inhibitors of RETBLUEPRINT MEDICINES CORP·Filed 2017·Granted Jan 22, 2019·13 cites·47 claims
- 0795US10035789B2Compounds useful for treating disorders related to RETBLUEPRINT MEDICINES CORP·Filed 2017·Granted Jul 31, 2018·31 cites·21 claims
- 0895US7960559B2Synthesis of enone intermediateHARVARD COLLEGE·Filed 2010·Granted Jun 14, 2011·13 cites·11 claims
- 0994US11534441B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 27, 2022·3 cites·25 claims
- 1093US11718602B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Aug 8, 2023·2 cites·8 claims
- 1193US10233186B2Inhibitors of activin receptor-like kinaseBLUEPRINT MEDICINES CORP·Filed 2017·Granted Mar 19, 2019·16 cites·56 claims
- 1293US8293920B2Synthesis of enone intermediateMYERS ANDREW G·Filed 2011·Granted Oct 23, 2012·8 cites·20 claims
- 1393US7807842B2Synthesis of tetracyclines and analogues thereofHARVARD COLLEGE·Filed 2005·Granted Oct 5, 2010·25 cites·11 claims
- 1492US8580969B2Synthesis of enone intermediateMYERS ANDREW G·Filed 2012·Granted Nov 12, 2013·7 cites·16 claims
- 1591US9969749B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted May 15, 2018·6 cites·4 claims
- 1691US8907104B2Synthesis of enone intermediateHARVARD COLLEGE·Filed 2013·Granted Dec 9, 2014·5 cites·20 claims
- 1790US12042495B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 1890US9932350B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Apr 3, 2018·5 cites·5 claims
- 1989US8486921B2Synthesis of tetracyclines and analogues thereofMYERS ANDREW G·Filed 2007·Granted Jul 16, 2013·10 cites·23 claims
- 2088US9943516B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Apr 17, 2018·5 cites·8 claims
- 2188US9926330B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Mar 27, 2018·5 cites·5 claims
- 2286US10040798B2Pyrrolopyridazine inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2016·Granted Aug 7, 2018·3 cites·4 claims
- 2385US10766883B2Aminopyrazoles as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Sep 8, 2020·3 cites·20 claims
- 2485US8598148B2Synthesis of tetracyclines and analogues thereofMYERS ANDREW G·Filed 2010·Granted Dec 3, 2013·7 cites·25 claims
- 2585US2024417386A1Inhibitors of retRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2683US11634422B2Inhibitors of activin receptor-like kinaseBLUEPRINT MEDICINES CORP·Filed 2020·Granted Apr 25, 2023·1 cites·30 claims
- 2782US10875847B2Aminopyrazoles as selective janus kinase inhibitorsINTERVET INC·Filed 2017·Granted Dec 29, 2020·2 cites·18 claims
- 2880US10669244B2Synthesis of tetracyclines and analogues thereofHARVARD COLLEGE·Filed 2018·Granted Jun 2, 2020·1 cites·20 claims
- 2980US9884830B2Synthesis of tetracyclines and analogues thereofHARVARD COLLEGE·Filed 2016·Granted Feb 6, 2018·2 cites·20 claims
- 3080US9365493B2Synthesis of tetracyclines and analogues thereofHARVARD COLLEGE·Filed 2013·Granted Jun 14, 2016·3 cites·22 claims
- 3180US2025289801A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Application pending·0 cites
- 3278US8592383B2Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulatorsHUANG XIANHAI·Filed 2012·Granted Nov 26, 2013·5 cites·48 claims
- 3377US12448379B2Wild type kit inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Granted Oct 21, 2025·0 cites·33 claims
- 3477US2022315560A1Inhibitors of retBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 3572US12172983B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 24, 2024·0 cites·21 claims
- 3672US11236086B2Substituted pyrrolopyridines as inhibitors of activin receptor-like kinaseBLUEPRINT MEDICINES CORP·Filed 2018·Granted Feb 1, 2022·1 cites·19 claims
- 3771US9725445B2Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·2 cites·17 claims
- 3870US11192866B2Synthesis of tetracyclines and analogues thereofHARVARD COLLEGE·Filed 2019·Granted Dec 7, 2021·0 cites·20 claims
- 3970US10329294B2Pyrazolopyrimidine inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2016·Granted Jun 25, 2019·1 cites·5 claims
- 4070US10329295B2Pyrrolotriazine inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2016·Granted Jun 25, 2019·1 cites·8 claims
- 4169US9394282B2Pyrazole carboxamides as Janus kinase inhibitorsBRUBAKER JASON·Filed 2012·Granted Jul 19, 2016·1 cites·20 claims
- 4268US8962608B2Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitorsBRUBAKER JASON·Filed 2012·Granted Feb 24, 2015·1 cites·17 claims
- 4361US12202844B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Jan 21, 2025·0 cites·30 claims
- 4460US2024336630A1Map4k1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4559US2024199648A1Map4k1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4658US2024299387A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4755US9493441B2Acyclic cyanoethylpyrazoles as janus kinase inhibitorsBRUBAKER JASON·Filed 2012·Granted Nov 15, 2016·0 cites·10 claims
- 4855US9328099B2Cyanomethylpyrazole carboxamides as janus kinase inhibitorsBRUBAKER JASON·Filed 2012·Granted May 3, 2016·0 cites·19 claims
- 4943US9957265B2N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·0 cites·11 claims
- 5037US8937077B2Bicyclic diamines as janus kinase inhibitorsGUERIN DAVID JOSEPH·Filed 2011·Granted Jan 20, 2015·0 cites·14 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jason D. Brubaker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →